Clinical Trial Update: Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether anakinra affects the antibody response to vaccines in patients with rheumatoid arthritis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED